Akums Drugs and Pharmaceuticals’ wholly-owned subsidiary -- Pure and Cure Healthcare has received approval from board for acquisition of Oriflame India’s manufacturing business for total consideration of Rs 56 crore. It includes two manufacturing plants at Roorkee, Uttarakhand and Noida, Uttar Pradesh, along with a leased warehouse situated at Noida. This will expand the company’s manufacturing capacity as well as capability of cosmetic and wellness products for Indian as well as global markets.
The said acquisition is expected to be completed by August 31, 2026. The Board of Directors of the company at their meeting held on July 23, 2026 has, inter alia, considered and approved the same.
Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1986.60 |
| Dr. Reddys Labs. | 1145.65 |
| Cipla | 1432.90 |
| Lupin | 2406.00 |
| Zydus Lifesciences | 1110.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: